20171103-广发证券_香港_-Dim_Sum_Express_4页_501kb
报告摘要
Dim Sum Express Summary
Key Index Performance
| Market | 1D Chg (%) | 1M Chg (%) | YTD Chg (%) | 17E EPS (%) | 18E EPS (%) | 17E P/E | 18E P/E |
|---|---|---|---|---|---|---|---|
| HSI | -0.3 | 1.2 | 29.6 | 22.8 | 8.6 | 12.9 | 11.9 |
| HSCEI | -0.3 | 2.6 | 23.5 | 9.6 | 9.4 | 8.8 | 8.1 |
| MXCN | -0.3 | 1.6 | 48.1 | 26.3 | 14.9 | 15.2 | 13.2 |
| SHSZ300 | 0.0 | 4.2 | 20.8 | 18.9 | 14.2 | 15.2 | 13.3 |
| SHCOMP | -0.4 | 1.0 | 9.0 | 27.6 | 12.6 | 14.6 | 13.0 |
| SZCOMP | -0.7 | 0.1 | 1.1 | 52.1 | 25.0 | 25.9 | 20.7 |
| INDU | 0.4 | 3.9 | 19.0 | 15.6 | 9.2 | 18.8 | 17.2 |
| SPX | 0.0 | 1.8 | 15.2 | 22.5 | 10.3 | 19.4 | 17.6 |
| CCMP | 0.0 | 2.8 | 24.7 | 54.2 | 13.3 | 24.0 | 21.2 |
| UKX | 0.9 | 1.2 | 5.8 | 164.1 | 6.3 | 15.2 | 14.3 |
| NKY | 0.5 | 9.3 | 17.9 | 37.8 | 11.4 | 19.3 | 17.3 |
Core Content and Key Information
China Property Market
- Primary sales area dropped: According to Soufun data, primary residential GFA sold decreased by 4% MoM and 32% YoY in October, confirming a bearish outlook for the 4Q17 property market.
- New down-cycle: The property market is believed to have entered a new down-cycle since September due to tightening policies and reduced property-related loans.
- 2018 outlook: Primary GFA sold is expected to drop by 10% YoY, which could challenge developers.
- Investor action: Most China property stocks may decline by 20-40% once the down-cycle is confirmed.
- Positive outlook on Bay Area landowners: Land prices in the Guangdong-Hong Kong-Macau Bay Area are expected to double over the next five years due to limited supply and increased demand.
CSPC Pharma (1093 HK)
- 3Q17 results expected: Results are likely to align with the full-year guidance of >30% YoY net profit growth.
- Pipeline products: Albumin-bound paclitaxel and clopidogrel are under regulatory review and expected to gain approval by end-2017.
- Generic drug growth: Generic drugs accounted for 44% of revenue in 1H17 and are expected to support growth.
- API upcycle: Continued growth in API (Active Pharmaceutical Ingredients) since 4Q16 is expected to provide further revenue and margin upside.
- Rating: Accumulate (expected to outperform benchmark by more than 5% but not more than 15%).
Huaneng Renewables (958 HK)
- Net profit growth misses: Shareholders' net profit grew 9% YoY, missing expectations.
- Wind power generation growth: Wind power generation increased by over 50% YoY in Xinjiang, Jilin, and Inner Mongolia due to reduced curtailment issues.
- Earnings forecasts: EPS is forecasted at Rmb0.274, 0.315, and 0.371 for 2017-2019, with P/E valuations at 8.5x, 7.4x, and 6.3x, which are relatively low.
- Key risks: Delays in subsidy payments, price cuts for subsidized wind power, and slower curtailment improvements.
Suntien Green Energy (956 HK)
- Wind power generation beat expectations: Wind power generation in 3Q17 increased by 147.28% YoY to 1.11bn kWh.
- Natural gas sales: Natural gas sales volume increased by 108.29% YoY to 3,372m m3, with retail sales up 271.3% YoY.
- Earnings forecasts: EPS is estimated at Rmb0.237, 0.292, and 0.370 for 2017-2019, with P/E valuations at 7.9x, 6.4x, and 5.1x.
- Key risks: Rising natural gas prices, declining electricity prices, usage restrictions, interest rate risk, and exchange rate fluctuations.
Company and Sector Ratings
Rating Definitions
- Buy: Expected to outperform benchmark by more than 15%
- Accumulate: Expected to outperform benchmark by more than 5% but not more than 15%
- Hold: Expected relative performance ranges between -5% and 5%
- Underperform: Expected to underperform benchmark by more than 5%
Sector Ratings
- Positive: Expected to outperform benchmark by more than 10%
- Neutral: Expected relative performance ranges between -10% and 10%
- Cautious: Expected to underperform benchmark by more than 10%
Analyst Certification and Disclosure
- The analysts certifying the report express personal views on the companies and securities mentioned.
- No part of their remuneration is directly tied to the recommendations in the report.
- GF Securities (Hong Kong) and its affiliates do not hold shares in the mentioned securities or have investment banking relationships with the companies in the past 12 months.
- Analysts and their associates do not serve as officers of the mentioned companies and have no financial interests in the securities.
Disclaimer
- This report is for informational purposes only and does not constitute an offer to buy or sell securities.
- The report is intended solely for GF Securities (Hong Kong) clients.
- The information may be subject to change without notice.
- GF Securities (Hong Kong) accepts no liability for losses arising from the use of the report.
- Recipients should consult professional advice before making investment decisions.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载